Modupe Elebute

3.0k total citations · 1 hit paper
30 papers, 2.0k citations indexed

About

Modupe Elebute is a scholar working on Immunology, Hematology and Genetics. According to data from OpenAlex, Modupe Elebute has authored 30 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Immunology, 22 papers in Hematology and 16 papers in Genetics. Recurrent topics in Modupe Elebute's work include Complement system in diseases (20 papers), Blood groups and transfusion (16 papers) and Hemoglobinopathies and Related Disorders (11 papers). Modupe Elebute is often cited by papers focused on Complement system in diseases (20 papers), Blood groups and transfusion (16 papers) and Hemoglobinopathies and Related Disorders (11 papers). Modupe Elebute collaborates with scholars based in United Kingdom, United States and Italy. Modupe Elebute's co-authors include Peter Hillmen, Russell P. Rother, Christopher F. Mojcik, Scott A. Rollins, Paul Browne, Jörg Schubert, Petra Muus, Gèrard Socié, Jeff Szer and Alexander Röth and has published in prestigious journals such as New England Journal of Medicine, Blood and British Journal of Haematology.

In The Last Decade

Modupe Elebute

30 papers receiving 1.9k citations

Hit Papers

The Complement Inhibitor Eculizumab in Paroxysmal Nocturn... 2006 2026 2012 2019 2006 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The Complement Inhibitor Eculizumab in Paroxysmal Nocturnal Hemoglobinuria
    2006 878 citations Peter Hillmen, Neal S. Young et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Modupe Elebute United Kingdom 12 1.7k 912 766 505 277 30 2.0k
Sara Gamba Italy 9 2.0k 1.2× 1.4k 1.5× 849 1.1× 374 0.7× 357 1.3× 14 2.3k
Federica Castelletti Italy 8 1.7k 1.0× 1.2k 1.3× 665 0.9× 292 0.6× 359 1.3× 8 1.9k
Chieh‐Lin Fu United States 8 1.3k 0.8× 741 0.8× 578 0.8× 414 0.8× 215 0.8× 17 1.5k
Jessica Caprioli Italy 17 2.7k 1.6× 1.7k 1.9× 1.2k 1.6× 528 1.0× 488 1.8× 25 3.1k
Rubén Martínez-Barricarte Spain 13 1.3k 0.8× 815 0.9× 582 0.8× 156 0.3× 108 0.4× 19 1.6k
Sara Gastoldi Italy 15 962 0.6× 625 0.7× 410 0.5× 195 0.4× 96 0.3× 32 1.3k
John‐Paul Westwood United Kingdom 13 995 0.6× 536 0.6× 580 0.8× 380 0.8× 46 0.2× 23 1.2k
Jefferson D. Upshaw United States 7 1.2k 0.7× 544 0.6× 905 1.2× 392 0.8× 38 0.1× 7 1.5k
Kenji Soejima Japan 21 1.5k 0.9× 566 0.6× 1.2k 1.6× 603 1.2× 30 0.1× 52 2.2k
Ara Metjian United States 14 617 0.4× 281 0.3× 447 0.6× 219 0.4× 37 0.1× 40 1.2k

Countries citing papers authored by Modupe Elebute

Since Specialization
Citations

This map shows the geographic impact of Modupe Elebute's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Modupe Elebute with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Modupe Elebute more than expected).

Fields of papers citing papers by Modupe Elebute

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Modupe Elebute. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Modupe Elebute. The network helps show where Modupe Elebute may publish in the future.

Co-authorship network of co-authors of Modupe Elebute

This figure shows the co-authorship network connecting the top 25 collaborators of Modupe Elebute. A scholar is included among the top collaborators of Modupe Elebute based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Modupe Elebute. Modupe Elebute is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Risitano, Antonio M., Michael Storek, Mittie K. Doyle, et al.. (2015). Safety and Pharmacokinetics of the Complement Inhibitor TT30 in a Phase I Trial for Untreated PNH Patients. Blood. 126(23). 2137–2137. 23 indexed citations
2.
3.
Szer, Jeff, Petra Muus, Alexander Röth, et al.. (2013). Long-term safety of sustained eculizumab treatment in patients with paroxysmal nocturnal hemoglobinuria. 4. 1 indexed citations
4.
Hill, Anita, Richard J. Kelly, Austin Kulasekararaj, et al.. (2012). Eculizumab in Paroxysmal Nocturnal Hemoglobinuria (PNH): A Report of All 153 Patients Treated in the UK. Blood. 120(21). 3472–3472. 13 indexed citations
5.
Szer, Jeff, Petra Muus, Modupe Elebute, et al.. (2012). Long-Term Safety of Sustained Eculizumab Treatment in Patients with Paroxysmal Nocturnal Hemoglobinuria. Blood. 120(21). 1260–1260. 2 indexed citations
6.
Jiang, Jie, Austin Kulasekararaj, Pramila Krishnamurthy, et al.. (2011). Telomere Length In MDS Patients Bone Marrow Is Highly Correlated with Complex Cytogenetics, IPSS Risk Groups and Transfusion Dependency,. Blood. 118(21). 3826–3826. 2 indexed citations
7.
Hillmen, Peter, Modupe Elebute, Richard J. Kelly, et al.. (2010). Long‐term effect of the complement inhibitor eculizumab on kidney function in patients with paroxysmal nocturnal hemoglobinuria. American Journal of Hematology. 85(8). 553–559. 140 indexed citations
8.
Elebute, Modupe & Judith Marsh. (2009). Autoimmune cytopenias. Medicine. 37(3). 159–163. 1 indexed citations
9.
Schubert, Jörg, Peter Hillmen, Alexander Röth, et al.. (2008). Eculizumab, a terminal complement inhibitor, improves anaemia in patients with paroxysmal nocturnal haemoglobinuria. British Journal of Haematology. 142(2). 263–272. 40 indexed citations
10.
Muus, Petra, Eric Van Den Neste, Ulrich Duehrsen, et al.. (2007). The clinical benefit of eculizumab is demonstrable in all subpopulations of patients with paroxysmal nocturnal hemoglobinuria (PNH) with hemolysis. 92. 137–138. 1 indexed citations
11.
Hillmen, Peter, Modupe Elebute, Richard Kelly, et al.. (2007). High Incidence of Progression to Chronic Renal Insufficiency in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH).. Blood. 110(11). 3678–3678. 13 indexed citations
12.
Marsh, Judith, J. Adam Tooze, G. Lucas, et al.. (2006). Lack of clinical efficacy of rituximab in the treatment of autoimmune neutropenia and pure red cell aplasia: implications for their pathophysiology. Annals of Hematology. 86(3). 191–197. 36 indexed citations
13.
Hillmen, Peter, Neal S. Young, Jörg Schubert, et al.. (2006). The Complement Inhibitor Eculizumab in Paroxysmal Nocturnal Hemoglobinuria. New England Journal of Medicine. 355(12). 1233–1243. 878 indexed citations breakdown →
14.
Hillmen, Peter, Claire Hall, Judith Marsh, et al.. (2004). Effect of Eculizumab on Hemolysis and Transfusion Requirements in Patients with Paroxysmal Nocturnal Hemoglobinuria. New England Journal of Medicine. 350(6). 552–559. 452 indexed citations
15.
Elebute, Modupe, Siân Rizzo, J. Adam Tooze, et al.. (2003). Evaluation of the haemopoietic reservoir in de novo haemolytic paroxysmal nocturnal haemoglobinuria. British Journal of Haematology. 123(3). 552–560. 11 indexed citations
16.
17.
Marsh, Judith & Modupe Elebute. (2003). Stem cells in paroxysmal nocturnal haemoglobinuria and aplastic anaemia: increasing evidence for overlap of haemopoietic defect. Transfusion Medicine. 13(6). 377–386. 11 indexed citations
18.
Elebute, Modupe, et al.. (2002). Autologous recovery following non-myeloablative unrelated donor bone marrow transplantation for severe aplastic anaemia. Annals of Hematology. 81(7). 378–381. 7 indexed citations
19.
Rizzo, Siân, John Scopes, Modupe Elebute, et al.. (2002). Stem cell defect in aplastic anemia: reduced long term culture-initiating cells (LTC-IC) in CD34+ cells isolated from aplastic anemia patient bone marrow. The Hematology Journal. 3(5). 230–236. 30 indexed citations
20.
Philpott, N. J., Modupe Elebute, R Powles, et al.. (1996). PLATINUM AGENTS AND SECONDARY MYELOID LEUKAEMIA: TWO CASES TREATED ONLY WITH PLATINUM‐BASED DRUGS. British Journal of Haematology. 93(4). 884–887. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sara Gamba Breakdown of academic impact, for papers by Federica Castelletti Breakdown of academic impact, for papers by Chieh‐Lin Fu Breakdown of academic impact, for papers by Jessica Caprioli Breakdown of academic impact, for papers by Rubén Martínez-Barricarte Breakdown of academic impact, for papers by Sara Gastoldi Breakdown of academic impact, for papers by John‐Paul Westwood Breakdown of academic impact, for papers by Jefferson D. Upshaw Breakdown of academic impact, for papers by Kenji Soejima Breakdown of academic impact, for papers by Ara Metjian
Rankless by CCL
2026